Literature DB >> 17219015

Pathology and immunology of lupus glomerulonephritis: can we bridge the two?

Helen Liapis1, George C Tsokos.   

Abstract

Aberrant immune responses underwrite lupus glomerulonephritis and may contribute to glomerular cell proliferation and inflammation. Recent studies provide evidence that apoptotic immune cells may initiate immune events leading to tissue damage. Nucleosomes within apoptotic particles are recognized by B cells and other antigen presenting cells and represent the most likely inciting antigen for autoantibody production. Some of these antibodies are nephritogenic depending on fine structural composition and antigen recognition in the circulation or on renal cells. Deficient complement components contribute to reduced clearance of circulating and native kidney apoptotic cells. This review summarizes current concepts in lupus immune pathogenesis and attempts to bridge immunology to pathology of lupus glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219015     DOI: 10.1007/s11255-006-9170-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  38 in total

1.  An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  C T Ravirajan; L Rowse; J R MacGowan; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-12       Impact factor: 7.580

Review 2.  Cellular penetration and nuclear localization of anti-DNA antibodies: mechanisms, consequences, implications and applications.

Authors:  M P Madaio; K Yanase
Journal:  J Autoimmun       Date:  1998-10       Impact factor: 7.094

Review 3.  Emerging concepts regarding B cells and autoantibodies in murine lupus nephritis. B cells have multiple roles; all autoantibodies are not equal.

Authors:  M P Madaio; M J Shlomchik
Journal:  J Am Soc Nephrol       Date:  1996-03       Impact factor: 10.121

4.  Immune cell signaling defects in lupus: activation, anergy and death.

Authors:  G C Tsokos; S N Liossis
Journal:  Immunol Today       Date:  1999-03

5.  Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.

Authors:  S Manzi; J E Rairie; A B Carpenter; R H Kelly; S P Jagarlapudi; S M Sereika; T A Medsger; R Ramsey-Goldman
Journal:  Arthritis Rheum       Date:  1996-07

Review 6.  Complement and apoptosis.

Authors:  Z Fishelson; G Attali; D Mevorach
Journal:  Mol Immunol       Date:  2001-08       Impact factor: 4.407

7.  Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent.

Authors:  F Niculescu; H Rus; T van Biesen; M L Shin
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

8.  Glomerular cell apoptosis in human lupus nephritis.

Authors:  Hirofumi Makino; Hitoshi Sugiyama; Yasushi Yamasaki; Yohei Maeshima; Jun Wada; Naoki Kashihara
Journal:  Virchows Arch       Date:  2003-05-15       Impact factor: 4.064

9.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

10.  Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.

Authors:  D Watanabe; T Suda; H Hashimoto; S Nagata
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

View more
  4 in total

1.  Semiquantitative and semi-automated morphometric evaluation of chronic lesions in renal biopsies.

Authors:  Daniel Abensur Athanazio; Gloria Maria Maranhão Sweet; Carlos Alberto Silva; Washington Luis Conrado dos-Santos
Journal:  Int Urol Nephrol       Date:  2008-11-07       Impact factor: 2.370

2.  Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe.

Authors:  N Sangala; R W Lee; C Horsfield; D J A Goldsmith
Journal:  Int Urol Nephrol       Date:  2009-08-15       Impact factor: 2.370

Review 3.  n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.

Authors:  James J Pestka
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-01       Impact factor: 4.006

4.  Unravelling the pathogenesis of lupus nephritis: novel genetic study confirms decisive contribution of circulating colony-stimulating factor-1 (CSF-1).

Authors:  Thomas Rauen; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2010-03-18       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.